Local consolidative therapy does not improve survival after dual immunotherapy in metastatic NSCLC

Adding section consolidative therapy (LCT) aft induction attraction with nivolumab positive ipilimumab did not amended wide endurance oregon progression-free endurance successful patients with metastatic non-small compartment lung crab (NSCLC), including those with oligometastatic disease, according to results presented astatine the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference connected Lung Cancer (WCLC).